Market Tracker

05/30 4:45pm ET

Dr.Reddy's Laboratories Ltd (NYSE:RDY)

46.29
Delayed Data
As of May 27
 +0.63 / +1.38%
Today’s Change
40.67
Today|||52-Week Range
68.00
0.00%
Year-to-Date
Growing Generic Drug Market a Good Opportuity for India Firms
3:34pm / GuruFocus News - Paid Partner Content
Dr. Reddy's (RDY) Acquires Ducere Pharma's OTC Brands
May 26 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close45.66
Today’s open46.40
Day’s range46.25 - 46.64
Volume184,696
Average volume (3 months)363,374
Market cap$7.9B
Dividend yield0.68%
Data as of 4:02pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-15.85%
Earnings growth (this year)--
Earnings growth (next 5 years)+8.79%
Revenue growth (last year)-2.51%
P/E ratio0.3
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
IDXXIDEXX Laboratories I...+0.33+0.37%
ALKSAlkermes Plc+1.84+4.15%
MNKMallinckrodt Plc+1.35+2.20%
JAZZJazz Pharmaceuticals...-0.68-0.45%
Data as of 4:02pm ET, 05/27/2016

Financials

Next reporting dateJuly 20, 2016
EPS forecast (this quarter)$0.51
Annual revenue (last year)$2.4B
Annual profit (last year)$305.0M
Net profit margin12.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Co-Chairman, Chief Executive Officer &
MD
Gunupati Venkateswara Prasad
President, CFO &
Global Head-IT
Saumen Chakraborty
Corporate headquarters
Hyderabad, Telangana

Forecasts